Hematology / Sickle Cell Disease

patient care perspectives by Michael Rutledge DeBaun, MD, MPH

Individuals with sickle cell disease (SCD) are at risk for heart, kidney, lung, and cerebrovascular diseases, and their life expectancy is shorter ...READ MORE

Hematology / Sickle Cell Disease

clinical topic updates by Julie Kanter, MD

The understanding of the cellular processes involved in vaso-occlusive crises (VOCs) in sickle cell disease (SCD) has expanded greatly. Data from o...READ MORE

Oncology / Non-Small Cell Lung Cancer

clinical topic updates by Jeffrey Crawford, MD

Immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized the treatment of late-stage non–small cell lung cancer (NSCLC). Emerging ...READ MORE

Oncology / Non-Small Cell Lung Cancer

expert roundtables by Jeffrey Crawford, MD; Bruce E. Johnson, MD; and Gregory J. Riely, MD, PhD

Dramatic advances have occurred in recent years in the treatment of non–small cell lung cancer (NSCLC). However, continued work is needed to achiev...READ MORE